The Drug Eluting Stents Center

Filter Your Results




Understanding Benefits and Risks of Drug-Eluting Stents

Ian T. Meredith, MBBS, PhD, AM

June 2019—Ongoing clinical studies will shed light on patient outcomes in real-world settings.

Orchestra BioMed Partners With Terumo to Develop and Commercialize the Virtue Sirolimus-Eluting Balloon

June 13, 2019 -- Orchestra BioMed, Inc. announced it has formed a global strategic partnership with Terumo Corporation for development and commercialization of Virtue sirolimu…

UK MHRA Issues Recommendations on Use of Paclitaxel Devices in PAD

June 6, 2019 -- The United Kingdom Medicines & Healthcare Products Regulatory Agency (UK MHRA) announced that it has issued the agency's recommendations for ongoing us…

Editorial Articles in JAHA Address Paclitaxel in PAD Studies

May 31, 2019 -- A series of editorial articles and letters published online in Journal of the American Heart Association (JAHA) continue to evaluate the data and discuss the c…

SWEDEPAD Trials Explore Resumption of Enrollment

May 31, 2019 -- Investigators from the SWEDEPAD 1 and 2 trials are aiming to resume recruitment of patients, having reviewed mortality data from the trials following conc…

Two-Year Data Presented From EffPac Trial of iVascular's Luminor DCB

May 23, 2019 -- iVascular announced that the 24-month EffPac trial results were presented by Professor Ulf Teichgräber, MD, at EuroPCR held May 21 -- 24 in Paris, France.…

PCR Issues Statement Supporting Continued Use of Paclitaxel-Based DCBs

May 21, 2019 -- PCR has issued a statement addressing the controversy on the use of paclitaxel drug-coated balloons (DCBs) in peripheral interventions. The statement concluded…

The SAVAL Trial

Jihad A. Mustapha, MD, FACC, FSCAI; Patrick Geraghty, MD, FACS; and Hans van Overhagen, MD, PhD, EBIR

May 2019—Details on the design and rationale behind this randomized trial studying infrapopliteal drug-eluting stent use for critical limb ischemia.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.